NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Enlivex Therapeutics Ltd (TA: ENLV)

 
ENLV Technical Analysis
5
As on 27th Nov 2025 ENLV STOCK Price closed @ 311.60 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 390.23 & Strong Sell for SHORT-TERM with Stoploss of 424.09 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ENLVSTOCK Price

Open 300.10 Change Price %
High 319.00 1 Day -19.00 -5.75
Low 300.10 1 Week -16.80 -5.12
Close 311.60 1 Month -60.60 -16.28
Volume 102252 1 Year -103.50 -24.93
52 Week High 614.90 | 52 Week Low 298.70
 
TA Israel Most Active Stocks
TA125 2008.05 1.06%
BEZQ 639.70 -0.99%
BLRX 1.80 -5.26%
ORL 103.20 1.67%
DSCT 3400.00 0.27%
LUMI 6810.00 0.98%
BONS 24.50 8.89%
ELAL 1397.00 -4.90%
MGDL 1320.00 0.99%
POLI 7027.00 0.62%
 
TA Israel Top Gainers Stocks
CNZN 105.00 94.44%
EMTC 22.00 17.65%
TDGN-L 171.50 17.55%
DORL 2941.00 17.41%
MCRNT 372.50 16.84%
CMER 3149.00 15.99%
GLTC 225.80 14.04%
GLTC 225.80 14.04%
GLTC 225.80 14.04%
HAMAT 1620.00 13.68%
 
TA Israel Top Losers Stocks
KMNK 51.00 -23.19%
KRNV 2.50 -21.88%
ULTR 74.10 -16.74%
HDST 35.00 -12.50%
HDST 35.00 -12.50%
MRHL 109.70 -12.45%
GLPL 1054.00 -10.45%
GLPL 1054.00 -10.45%
MEAT 0.77 -9.41%
MEAT 0.77 -9.41%
 
 
ENLV
Daily Charts
ENLV
Intraday Charts
Whats New @
Bazaartrend
ENLV
Free Analysis
 
ENLV Important Levels Intraday
RESISTANCE348.02
RESISTANCE336.34
RESISTANCE329.12
RESISTANCE321.90
SUPPORT301.30
SUPPORT294.08
SUPPORT286.86
SUPPORT275.18
 
ENLV Forecast November 2025
4th UP Forecast502.18
3rd UP Forecast441.06
2nd UP Forecast403.28
1st UP Forecast365.5
1st DOWN Forecast257.7
2nd DOWN Forecast219.92
3rd DOWN Forecast182.14
4th DOWN Forecast121.02
 
ENLV Weekly Forecast
4th UP Forecast431.07
3rd UP Forecast392.76
2nd UP Forecast369.07
1st UP Forecast345.39
1st DOWN Forecast277.81
2nd DOWN Forecast254.13
3rd DOWN Forecast230.44
4th DOWN Forecast192.13
 
ENLV Forecast2025
4th UP Forecast1059.08
3rd UP Forecast819.36
2nd UP Forecast671.18
1st UP Forecast523.01
1st DOWN Forecast100.19
2nd DOWN Forecast-47.98
3rd DOWN Forecast-196.16
4th DOWN Forecast-435.88
 
 
ENLV Other Details
Segment EQ
Market Capital 50720083968.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ENLV Address
ENLV
 
ENLV Latest News
 
Your Comments and Response on Enlivex Therapeutics Ltd
 
ENLV Business Profile
Enlivex Therapeutics Ltd. operates as a clinical stage immunotherapy company. It is developing Allocetra, an off-the-shelf cell therapy designed to reprogram macrophages into homeostatic state. Resetting non-homeostatic macrophages into homeostatic state is critical for immune system rebalancing and resolution of life-threatening conditions. Diseases, such as solid cancers, sepsis, COVID-19, and others reprogram macrophages out of homeostatic state. Its Allocetra has the potential to provide a novel immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents. The company has a research collaboration with Yale Cancer Center for the assessment of Allocetra to enhance the activity of checkpoint inhibitors in solid tumors. Enlivex Therapeutics Ltd. was incorporated in 2005 and is headquartered in Nes Ziona, Israel. Address: 14 Einstein Street, Ness Ziona, Israel, 7403618
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service